Mr. Speaker, as I said, the voluntary system is working to a certain extent to ensure that those drugs are posted and that we are aware of what drugs can be used to replace them.
However, the member has to recognize that these consultations are important, because not all drug shortages will be fixed through mandatory reporting. It can be a much more complex issue on a global scale in terms of the kinds of shortages that we have seen.
We are working very closely with the provinces and the territories and the drug manufacturers to make sure, whether it is voluntary or mandatory, that we are addressing drug shortages.